{"transactions":[{"id":768657,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":34848,"kind":"person","name":"YARNO WENDY L","position":1,"cik":"0001181186","reported_name":"YARNO WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:49:47.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."}],"balance_after":34200,"derivative":{"underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001181186-26-000002","document":"wk-form4_1779396584.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000118118626000002/wk-form4_1779396584.xml","form_type":"4"}},{"id":768656,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":34848,"kind":"person","name":"YARNO WENDY L","position":1,"cik":"0001181186","reported_name":"YARNO WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2026-05-21T20:49:47.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 20, 2027."}],"balance_after":41800,"derivative":{"exercise_price":1.23,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001181186-26-000002","document":"wk-form4_1779396584.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000118118626000002/wk-form4_1779396584.xml","form_type":"4"}},{"id":768655,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":30802,"kind":"person","name":"Shepard Jay","position":1,"cik":"0001587788","reported_name":"Shepard Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:32:04.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."}],"balance_after":34200,"derivative":{"underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001587788-26-000002","document":"wk-form4_1779395521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000158778826000002/wk-form4_1779395521.xml","form_type":"4"}},{"id":768654,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":30802,"kind":"person","name":"Shepard Jay","position":1,"cik":"0001587788","reported_name":"Shepard Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2026-05-21T20:32:04.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 20, 2027."}],"balance_after":41800,"derivative":{"exercise_price":1.23,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001587788-26-000002","document":"wk-form4_1779395521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000158778826000002/wk-form4_1779395521.xml","form_type":"4"}},{"id":768651,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45393,"kind":"person","name":"Miller Ann Calby","position":1,"cik":"0001771423","reported_name":"Miller Ann Calby","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:11:55.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."}],"balance_after":34200,"derivative":{"underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001771423-26-000001","document":"wk-form4_1779394312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177142326000001/wk-form4_1779394312.xml","form_type":"4"}},{"id":768650,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45393,"kind":"person","name":"Miller Ann Calby","position":1,"cik":"0001771423","reported_name":"Miller Ann Calby","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2026-05-21T20:11:55.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 20, 2027."}],"balance_after":41800,"derivative":{"exercise_price":1.23,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001771423-26-000001","document":"wk-form4_1779394312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177142326000001/wk-form4_1779394312.xml","form_type":"4"}},{"id":768653,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:11:24.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."}],"balance_after":34200,"derivative":{"underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001669080-26-000003","document":"wk-form4_1779394282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000166908026000003/wk-form4_1779394282.xml","form_type":"4"}},{"id":768652,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2026-05-21T20:11:24.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 20, 2027."}],"balance_after":41800,"derivative":{"exercise_price":1.23,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001669080-26-000003","document":"wk-form4_1779394282.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000166908026000003/wk-form4_1779394282.xml","form_type":"4"}},{"id":768649,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":37177,"kind":"person","name":"Zoth Lota S.","position":1,"cik":"0001278219","reported_name":"Zoth Lota S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:10:48.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."}],"balance_after":34200,"derivative":{"underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001278219-26-000001","document":"wk-form4_1779394245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000127821926000001/wk-form4_1779394245.xml","form_type":"4"}},{"id":768648,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":37177,"kind":"person","name":"Zoth Lota S.","position":1,"cik":"0001278219","reported_name":"Zoth Lota S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2026-05-21T20:10:48.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 20, 2027."}],"balance_after":41800,"derivative":{"exercise_price":1.23,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001278219-26-000001","document":"wk-form4_1779394245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000127821926000001/wk-form4_1779394245.xml","form_type":"4"}},{"id":768647,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45392,"kind":"person","name":"DANSEY ROGER D","position":1,"cik":"0001741836","reported_name":"DANSEY ROGER D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:06:49.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."}],"balance_after":34200,"derivative":{"underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001741836-26-000005","document":"wk-form4_1779394006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000174183626000005/wk-form4_1779394006.xml","form_type":"4"}},{"id":768646,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45392,"kind":"person","name":"DANSEY ROGER D","position":1,"cik":"0001741836","reported_name":"DANSEY ROGER D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2026-05-21T20:06:49.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 20, 2027."}],"balance_after":41800,"derivative":{"exercise_price":1.23,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001741836-26-000005","document":"wk-form4_1779394006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000174183626000005/wk-form4_1779394006.xml","form_type":"4"}},{"id":768640,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45390,"kind":"person","name":"BENITO SIMON X","position":1,"cik":"0001273306","reported_name":"BENITO SIMON X","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:06:21.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 20, 2027."}],"balance_after":34200,"derivative":{"underlying":"Common Stock","underlying_shares":34200},"source":{"system":"sec-edgar","filing":"0001273306-26-000001","document":"wk-form4_1779393978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000127330626000001/wk-form4_1779393978.xml","form_type":"4"}},{"id":768639,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45390,"kind":"person","name":"BENITO SIMON X","position":1,"cik":"0001273306","reported_name":"BENITO SIMON X","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2026-05-21T20:06:21.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":41800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant was made under the 2023 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options to vest 100% on May 20, 2027."}],"balance_after":41800,"derivative":{"exercise_price":1.23,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":41800},"source":{"system":"sec-edgar","filing":"0001273306-26-000001","document":"wk-form4_1779393978.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000127330626000001/wk-form4_1779393978.xml","form_type":"4"}},{"id":768645,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":27440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"date","element":"transactionDate","label":"F6","text":"The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 9,147 shares will vest on February 26, 2027; 9,147 shares will vest on February 26, 2028; and 9,146 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":27440,"derivative":{"underlying":"Common Stock","underlying_shares":27440},"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768644,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":34160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the options granted on May 20, 2026 was as follows: 11,387 shares will vest on February 26, 2027; 11,387 shares will vest on February 26, 2028; 11,386 shares will vest on February 26, 2029."}],"balance_after":34160,"derivative":{"exercise_price":1.73,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":34160},"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768643,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":6027,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":12054,"derivative":{"underlying":"Common Stock","underlying_shares":6027},"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768642,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2163,"price":1.23,"value":2660.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":46823,"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768641,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:05:47.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":6027,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units was as follows: 6,027 shares vested on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":48986,"source":{"system":"sec-edgar","filing":"0001770390-26-000005","document":"wk-form4_1779393944.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000005/wk-form4_1779393944.xml","form_type":"4"}},{"id":768638,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:05:17.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":37684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 12,562 shares will vest on February 26, 2027; 12,561 shares will vest on February 26, 2028; 12,561 and  shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"date","element":"transactionDate","label":"F6","text":"The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 12,562 shares will vest on February 26, 2027; 12,561 shares will vest on February 26, 2028; 12,561 and  shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 12,562 shares will vest on February 26, 2027; 12,561 shares will vest on February 26, 2028; 12,561 and  shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":37684,"derivative":{"underlying":"Common Stock","underlying_shares":37684},"source":{"system":"sec-edgar","filing":"0001936799-26-000006","document":"wk-form4_1779393902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000006/wk-form4_1779393902.xml","form_type":"4"}},{"id":768637,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Option","published_at":"2026-05-21T20:05:17.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":46876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the options granted on May 20, 2026 was as follows: 15,626 shares will vest on February 26, 2027; 15,625 shares will vest on February 26, 2028; 15,625 shares will vest on February 26, 2029."}],"balance_after":46876,"derivative":{"exercise_price":1.73,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":46876},"source":{"system":"sec-edgar","filing":"0001936799-26-000006","document":"wk-form4_1779393902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000006/wk-form4_1779393902.xml","form_type":"4"}},{"id":768636,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:05:17.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":9450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":18900,"derivative":{"underlying":"Common Stock","underlying_shares":9450},"source":{"system":"sec-edgar","filing":"0001936799-26-000006","document":"wk-form4_1779393902.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000006/wk-form4_1779393902.xml","form_type":"4"}},{"id":768635,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:05:17.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":2693,"price":1.23,"value":3312.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":42038,"source":{"system":"sec-edgar","filing":"0001936799-26-000006","document":"wk-form4_1779393902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000006/wk-form4_1779393902.xml","form_type":"4"}},{"id":768634,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:05:17.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":9450,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 28,350 restricted stock units was as follows: 9,450 shares vested on May 20, 2026; 9,450 shares will vest on May 20, 2027; 9,450 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":44731,"source":{"system":"sec-edgar","filing":"0001936799-26-000006","document":"wk-form4_1779393902.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000006/wk-form4_1779393902.xml","form_type":"4"}},{"id":768626,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":32480,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"date","element":"transactionDate","label":"F6","text":"The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 10,827 shares will vest on February 26, 2027; 10,827 shares will vest on February 26, 2028; and 10,826 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":32480,"derivative":{"underlying":"Common Stock","underlying_shares":32480},"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768625,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":39760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the options granted on May 20, 2026 was as follows: 13,254 shares will vest on February 26, 2027; 13,253 shares will vest on February 26, 2028; 13,253 shares will vest on February 26, 2029."}],"balance_after":39760,"derivative":{"exercise_price":1.73,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":39760},"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768624,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":8700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":17400,"derivative":{"underlying":"Common Stock","underlying_shares":8700},"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768623,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":4688,"price":1.23,"value":5766.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":42854,"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768622,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-21T20:04:32.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":8700,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units was as follows: 8,700 shares vested on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":47542,"source":{"system":"sec-edgar","filing":"0001259780-26-000006","document":"wk-form4_1779393868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000006/wk-form4_1779393868.xml","form_type":"4"}},{"id":768631,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":100240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"date","element":"transactionDate","label":"F6","text":"The restricted stock units were approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the restricted stock units were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the restricted stock units granted on May 20, 2026 was as follows: 33,414 shares will vest on February 26, 2027; 33,413 shares will vest on February 26, 2028; and 33,413 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":100240,"derivative":{"underlying":"Common Stock","underlying_shares":100240},"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":768630,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":123760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The stock option grant was approved by Inovio's Board of Directors on March 4, 2026, subject to shareholder approval of the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan under which the stock options were granted. Inovio's shareholders approved the amendment and restatement of the Amended and Restated 2023 Omnibus Incentive Plan on May 20, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting schedule for the options granted on May 20, 2026 was as follows: 41,254 shares will vest on February 26, 2027; 41,253 shares will vest on February 26, 2028; 41,253 shares will vest on February 26, 2029."}],"balance_after":123760,"derivative":{"exercise_price":1.73,"expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":123760},"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":768629,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":false,"shares":28296,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":56592,"derivative":{"underlying":"Common Stock","underlying_shares":28296},"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":768628,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":12306,"price":1.23,"value":15136.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":111021,"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":768627,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-21T20:04:02.000Z","date":"2026-05-20","kind":"exercise","planned":false,"acquired":true,"shares":28296,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units was as follows: 28,296 shares vested on May 20, 2026; 28,296 shares will vest on May 20, 2027; 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":123327,"source":{"system":"sec-edgar","filing":"0001771498-26-000005","document":"wk-form4_1779393839.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000005/wk-form4_1779393839.xml","form_type":"4"}},{"id":775630,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-18T20:08:07.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":17744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17744},"source":{"system":"sec-edgar","filing":"0001771498-26-000004","document":"wk-form4_1779134885.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000004/wk-form4_1779134885.xml","form_type":"4"}},{"id":775629,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:08:07.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":7717,"price":1.3,"value":10032.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":95031,"source":{"system":"sec-edgar","filing":"0001771498-26-000004","document":"wk-form4_1779134885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000004/wk-form4_1779134885.xml","form_type":"4"}},{"id":775628,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:08:07.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":17744,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 53,233 restricted stock units was as follows: 17,745 shares vested on May 15, 2024; 17,744 shares vested on May 15, 2025; and 17,744 shares vested on May 15, 2026. Vested restricted stock units could be settled in shares of common stock, cash or a combination of both."}],"balance_after":102748,"source":{"system":"sec-edgar","filing":"0001771498-26-000004","document":"wk-form4_1779134885.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000004/wk-form4_1779134885.xml","form_type":"4"}},{"id":775627,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-05-18T20:07:30.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":4771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4771},"source":{"system":"sec-edgar","filing":"0001259780-26-000005","document":"wk-form4_1779134848.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000005/wk-form4_1779134848.xml","form_type":"4"}},{"id":775626,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-18T20:07:30.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":2571,"price":1.3,"value":3342.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":38842,"source":{"system":"sec-edgar","filing":"0001259780-26-000005","document":"wk-form4_1779134848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000005/wk-form4_1779134848.xml","form_type":"4"}},{"id":775625,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-05-18T20:07:30.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":4771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":41413,"source":{"system":"sec-edgar","filing":"0001259780-26-000005","document":"wk-form4_1779134848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000005/wk-form4_1779134848.xml","form_type":"4"}},{"id":775624,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-18T20:06:42.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":4771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4771},"source":{"system":"sec-edgar","filing":"0001770390-26-000004","document":"wk-form4_1779134799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000004/wk-form4_1779134799.xml","form_type":"4"}},{"id":775623,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:06:42.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1712,"price":1.3,"value":2225.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":42959,"source":{"system":"sec-edgar","filing":"0001770390-26-000004","document":"wk-form4_1779134799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000004/wk-form4_1779134799.xml","form_type":"4"}},{"id":775622,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:06:42.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":4771,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 14,313 restricted stock units was as follows: 4,771 shares vested on May 15, 2024; 4,771 shares vested on May 15, 2025; and 4,771 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":44671,"source":{"system":"sec-edgar","filing":"0001770390-26-000004","document":"wk-form4_1779134799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000004/wk-form4_1779134799.xml","form_type":"4"}},{"id":775620,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-05-18T20:04:56.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":false,"shares":2385,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2385},"source":{"system":"sec-edgar","filing":"0001936799-26-000005","document":"wk-form4_1779134693.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000005/wk-form4_1779134693.xml","form_type":"4"}},{"id":775619,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:04:56.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":680,"price":1.3,"value":884.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":35281,"source":{"system":"sec-edgar","filing":"0001936799-26-000005","document":"wk-form4_1779134693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000005/wk-form4_1779134693.xml","form_type":"4"}},{"id":775618,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-05-18T20:04:56.000Z","date":"2026-05-15","kind":"exercise","planned":false,"acquired":true,"shares":2385,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 7,156 restricted stock units was as follows: 2,386 shares vested on May 15, 2024; 2,385 shares vested on May 15, 2025; and 2,385 shares vested on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":35961,"source":{"system":"sec-edgar","filing":"0001936799-26-000005","document":"wk-form4_1779134693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000005/wk-form4_1779134693.xml","form_type":"4"}},{"id":823342,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-04-01T21:05:12.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":false,"shares":4292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4292},"source":{"system":"sec-edgar","filing":"0001936799-26-000004","document":"wk-form4_1775077509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000004/wk-form4_1775077509.xml","form_type":"4"}},{"id":823341,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:05:12.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1223,"price":1.74,"value":2128.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":33576,"source":{"system":"sec-edgar","filing":"0001936799-26-000004","document":"wk-form4_1775077509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000004/wk-form4_1775077509.xml","form_type":"4"}},{"id":823340,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-04-01T21:05:12.000Z","date":"2026-03-31","kind":"exercise","planned":false,"acquired":true,"shares":4292,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on March 31, 2026."}],"balance_after":34799,"source":{"system":"sec-edgar","filing":"0001936799-26-000004","document":"wk-form4_1775077509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000004/wk-form4_1775077509.xml","form_type":"4"}},{"id":859349,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T21:55:40.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":21560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 21,560 restricted stock units granted on March 4, 2026 was as follows: 7,187 shares will vest on February 26, 2027; 7,187 shares will vest on February 26, 2028; and 7,186 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":21560,"derivative":{"underlying":"Common Stock","underlying_shares":21560},"source":{"system":"sec-edgar","filing":"0001770390-26-000003","document":"wk-form4_1772747737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000003/wk-form4_1772747737.xml","form_type":"4"}},{"id":859348,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2026-03-05T21:55:40.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":26840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 26,840 options granted on March 4, 2026 was as follows: 8,947 shares will vest on February 26, 2027; 8,947 shares will vest on February 26, 2028; 8,946 shares will vest on February 26, 2029."}],"balance_after":26840,"derivative":{"exercise_price":1.73,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":26840},"source":{"system":"sec-edgar","filing":"0001770390-26-000003","document":"wk-form4_1772747737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000003/wk-form4_1772747737.xml","form_type":"4"}},{"id":859346,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T21:55:11.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":78760,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 78,760 restricted stock units granted on March 4, 2026 was as follows: 26,254 shares will vest on February 26, 2027; 26,253 shares will vest on February 26, 2028; and 26,253 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":78760,"derivative":{"underlying":"Common Stock","underlying_shares":78760},"source":{"system":"sec-edgar","filing":"0001771498-26-000003","document":"wk-form4_1772747707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000003/wk-form4_1772747707.xml","form_type":"4"}},{"id":859345,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2026-03-05T21:55:11.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":97240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 97,240 options granted on March 4, 2026 was as follows: 32,414 shares will vest on February 26, 2027; 32,413 shares will vest on February 26, 2028; 32,413 shares will vest on February 26, 2029."}],"balance_after":97240,"derivative":{"exercise_price":1.73,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":97240},"source":{"system":"sec-edgar","filing":"0001771498-26-000003","document":"wk-form4_1772747707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000003/wk-form4_1772747707.xml","form_type":"4"}},{"id":859344,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T21:54:42.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":29608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 29,608 restricted stock units granted on March 4, 2026 was as follows: 9,870 shares will vest on February 26, 2027; 9,869 shares will vest on February 26, 2028; and 9,869 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":29608,"derivative":{"underlying":"Common Stock","underlying_shares":29608},"source":{"system":"sec-edgar","filing":"0001936799-26-000003","document":"wk-form4_1772747679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000003/wk-form4_1772747679.xml","form_type":"4"}},{"id":859343,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock Option","published_at":"2026-03-05T21:54:42.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":36832,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 36,832 options granted on March 4, 2026 was as follows: 12,278 shares will vest on February 26, 2027; 12,277 shares will vest on February 26, 2028; 12,277 shares will vest on February 26, 2029."}],"balance_after":36832,"derivative":{"exercise_price":1.73,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":36832},"source":{"system":"sec-edgar","filing":"0001936799-26-000003","document":"wk-form4_1772747679.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000003/wk-form4_1772747679.xml","form_type":"4"}},{"id":859340,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T21:54:10.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":25520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 25,520 restricted stock units granted on March 4, 2026 was as follows: 8,507 shares will vest on February 26, 2027; 8,507 shares will vest on February 26, 2028; and 8,506 shares will vest on February 26, 2029. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":25520,"derivative":{"underlying":"Common Stock","underlying_shares":25520},"source":{"system":"sec-edgar","filing":"0001259780-26-000004","document":"wk-form4_1772747645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000004/wk-form4_1772747645.xml","form_type":"4"}},{"id":859339,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2026-03-05T21:54:10.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":31240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The vesting schedule for the 31,240 options granted on March 4, 2026 was as follows: 10,414 shares will vest on February 26, 2027; 10,413 shares will vest on February 26, 2028; 10,413 shares will vest on February 26, 2029."}],"balance_after":31240,"derivative":{"exercise_price":1.73,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":31240},"source":{"system":"sec-edgar","filing":"0001259780-26-000004","document":"wk-form4_1772747645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000004/wk-form4_1772747645.xml","form_type":"4"}},{"id":878029,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":7366,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":14732,"derivative":{"underlying":"Common Stock","underlying_shares":7366},"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878028,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":5009,"derivative":{"underlying":"Common Stock","underlying_shares":5010},"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878027,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3034,"price":1.79,"value":5430.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878026,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":7366,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 22,098 restricted stock units granted on February 27, 2025 was as follows: 7,366 shares vested on February 26, 2026; 7,366 shares will vest on February 26, 2027; 7,366 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":42934,"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878025,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2064,"price":1.79,"value":3694.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":35568,"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878024,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:49:03.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":37632,"source":{"system":"sec-edgar","filing":"0001770390-26-000002","document":"wk-form4_1772228940.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177039026000002/wk-form4_1772228940.xml","form_type":"4"}},{"id":878023,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":10634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":21266,"derivative":{"underlying":"Common Stock","underlying_shares":10634},"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878022,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":5009,"derivative":{"underlying":"Common Stock","underlying_shares":5010},"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878021,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":6294,"price":1.79,"value":11266.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":36642,"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878020,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":10634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 31,900 restricted stock units granted on February 27, 2025 was as follows: 10,634 shares vested on February 26, 2026; 10,633 shares will vest on February 26, 2027; 10,633 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":42936,"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878019,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":2965,"price":1.79,"value":5307.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":32302,"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878018,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2026-02-27T21:48:27.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":35267,"source":{"system":"sec-edgar","filing":"0001259780-26-000002","document":"wk-form4_1772228904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000125978026000002/wk-form4_1772228904.xml","form_type":"4"}},{"id":878012,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":28401,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":56800,"derivative":{"underlying":"Common Stock","underlying_shares":28401},"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878011,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":18632,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":18631,"derivative":{"underlying":"Common Stock","underlying_shares":18632},"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878010,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":13657,"price":1.79,"value":24446.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (3) herein."}],"balance_after":85004,"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878009,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":28401,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 85,201 restricted stock units granted on February 27, 2025 was as follows: 28,401 shares vested on February 26, 2026; 28,400 shares will vest on February 26, 2027; 28,400 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":98661,"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878008,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":8057,"price":1.79,"value":14422.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (1) herein."}],"balance_after":70260,"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878007,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:50.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":18632,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 55,895 restricted stock units granted on February 28, 2024 was as follows: 18,632 shares vested on February 26, 2025; 18,632 shares vested on February 26, 2026; and 18,631 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":78317,"source":{"system":"sec-edgar","filing":"0001771498-26-000002","document":"wk-form4_1772228868.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000177149826000002/wk-form4_1772228868.xml","form_type":"4"}},{"id":878017,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:47:13.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":11550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":23100,"derivative":{"underlying":"Common Stock","underlying_shares":11550},"source":{"system":"sec-edgar","filing":"0001936799-26-000002","document":"wk-form4_1772228830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000002/wk-form4_1772228830.xml","form_type":"4"}},{"id":878016,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:47:13.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":5010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":5009,"derivative":{"underlying":"Common Stock","underlying_shares":5010},"source":{"system":"sec-edgar","filing":"0001936799-26-000002","document":"wk-form4_1772228830.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000002/wk-form4_1772228830.xml","form_type":"4"}},{"id":878015,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:13.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3903,"price":1.79,"value":6986.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in the immediately preceding row and described in footnote (2) herein."}],"balance_after":30507,"source":{"system":"sec-edgar","filing":"0001936799-26-000002","document":"wk-form4_1772228830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000002/wk-form4_1772228830.xml","form_type":"4"}},{"id":878014,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:13.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":11550,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 34,650 restricted stock units granted on February 27, 2025 was as follows: 11,550 shares vested on February 26, 2026; 11,550 shares will vest on February 26, 2027; 11,550 shares will vest on February 26, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":34410,"source":{"system":"sec-edgar","filing":"0001936799-26-000002","document":"wk-form4_1772228830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000002/wk-form4_1772228830.xml","form_type":"4"}},{"id":878013,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-27T21:47:13.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":5010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 15,029 restricted stock units granted on February 28, 2024 was as follows: 5,010 shares vested on February 26, 2025; 5,010 shares vested on February 26, 2026; and 5,009 shares will vest on February 26, 2027.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":22860,"source":{"system":"sec-edgar","filing":"0001936799-26-000002","document":"wk-form4_1772228830.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000193679926000002/wk-form4_1772228830.xml","form_type":"4"}},{"id":878006,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-02-27T21:44:20.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":false,"shares":972,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":972},"source":{"system":"sec-edgar","filing":"0001669080-26-000002","document":"wk-form4_1772228657.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000166908026000002/wk-form4_1772228657.xml","form_type":"4"}},{"id":878005,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45394,"kind":"person","name":"Weiner David B.","position":1,"cik":"0001669080","reported_name":"Weiner David B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-27T21:44:20.000Z","date":"2026-02-26","kind":"exercise","planned":false,"acquired":true,"shares":972,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 2,916 restricted stock units granted on February 27, 2023 was as follows: 972 shares vested on February 26, 2024; 972 shares vested on February 26, 2025; and 972 shares vested on February 26, 2026.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":87592,"source":{"system":"sec-edgar","filing":"0001669080-26-000002","document":"wk-form4_1772228657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000166908026000002/wk-form4_1772228657.xml","form_type":"4"}},{"id":1098290,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-07-01T20:08:06.000Z","date":"2025-06-30","kind":"exercise","planned":false,"acquired":false,"shares":2916,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2916},"source":{"system":"sec-edgar","filing":"0001055726-25-000046","document":"wk-form4_1751400477.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000046/wk-form4_1751400477.xml","form_type":"4"}},{"id":1098289,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45389,"kind":"person","name":"Sumner Michael John","position":1,"cik":"0001936799","reported_name":"Sumner Michael John","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-07-01T20:08:06.000Z","date":"2025-06-30","kind":"exercise","planned":false,"acquired":true,"shares":2916,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":17850,"source":{"system":"sec-edgar","filing":"0001055726-25-000046","document":"wk-form4_1751400477.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000046/wk-form4_1751400477.xml","form_type":"4"}},{"id":1139383,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Option","published_at":"2025-05-21T20:58:59.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":105262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting schedule for the 105,262 options is as follows: 52,631 shares will vest on May 20, 2027 and 52,631 shares will vest on May 20, 2028."}],"balance_after":105262,"derivative":{"exercise_price":2.13,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":105262},"source":{"system":"sec-edgar","filing":"0001055726-25-000042","document":"wk-form4_1747861132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000042/wk-form4_1747861132.xml","form_type":"4"}},{"id":1139382,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45388,"kind":"person","name":"Shea Jacqueline Elizabeth","position":1,"cik":"0001771498","reported_name":"Shea Jacqueline Elizabeth","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:58:59.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":84888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 84,888 restricted stock units is as follows: 28,296 shares will vest on May 20, 2026; 28,296 shares will vest on May 20, 2027; and 28,296 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":84888,"derivative":{"underlying":"Common Stock","underlying_shares":84888},"source":{"system":"sec-edgar","filing":"0001055726-25-000042","document":"wk-form4_1747861132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000042/wk-form4_1747861132.xml","form_type":"4"}},{"id":1139374,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock Option","published_at":"2025-05-21T20:58:48.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":22419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting schedule for the 22,419 options is as follows: 11,210 shares will vest on May 20, 2027 and 11,209 shares will vest on May 20, 2028."}],"balance_after":22419,"derivative":{"exercise_price":2.13,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":22419},"source":{"system":"sec-edgar","filing":"0001055726-25-000041","document":"wk-form4_1747861122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000041/wk-form4_1747861122.xml","form_type":"4"}},{"id":1139373,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45391,"kind":"person","name":"Humeau Laurent","position":1,"cik":"0001770390","reported_name":"Humeau Laurent","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:58:48.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":18081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units is as follows: 6,027 shares will vest on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units is as follows: 6,027 shares will vest on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 18,081 restricted stock units is as follows: 6,027 shares will vest on May 20, 2026; 6,027 shares will vest on May 20, 2027; 6,027 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":18081,"derivative":{"underlying":"Common Stock","underlying_shares":18081},"source":{"system":"sec-edgar","filing":"0001055726-25-000041","document":"wk-form4_1747861122.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000041/wk-form4_1747861122.xml","form_type":"4"}},{"id":1139372,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":37177,"kind":"person","name":"Zoth Lota S.","position":1,"cik":"0001278219","reported_name":"Zoth Lota S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:58:38.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":2167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2167},"source":{"system":"sec-edgar","filing":"0001055726-25-000040","document":"wk-form4_1747861110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000040/wk-form4_1747861110.xml","form_type":"4"}},{"id":1139371,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":37177,"kind":"person","name":"Zoth Lota S.","position":1,"cik":"0001278219","reported_name":"Zoth Lota S.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:58:38.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":2167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":8726,"source":{"system":"sec-edgar","filing":"0001055726-25-000040","document":"wk-form4_1747861110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000040/wk-form4_1747861110.xml","form_type":"4"}},{"id":1139370,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45393,"kind":"person","name":"Miller Ann Calby","position":1,"cik":"0001771423","reported_name":"Miller Ann Calby","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:58:26.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":2167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2167},"source":{"system":"sec-edgar","filing":"0001055726-25-000039","document":"wk-form4_1747861099.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000039/wk-form4_1747861099.xml","form_type":"4"}},{"id":1139369,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45393,"kind":"person","name":"Miller Ann Calby","position":1,"cik":"0001771423","reported_name":"Miller Ann Calby","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:58:26.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":2167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":9877,"source":{"system":"sec-edgar","filing":"0001055726-25-000039","document":"wk-form4_1747861099.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000039/wk-form4_1747861099.xml","form_type":"4"}},{"id":1139368,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":30802,"kind":"person","name":"Shepard Jay","position":1,"cik":"0001587788","reported_name":"Shepard Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:58:15.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":2167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2167},"source":{"system":"sec-edgar","filing":"0001055726-25-000038","document":"wk-form4_1747861088.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000038/wk-form4_1747861088.xml","form_type":"4"}},{"id":1139367,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":30802,"kind":"person","name":"Shepard Jay","position":1,"cik":"0001587788","reported_name":"Shepard Jay","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:58:15.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":2167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":9209,"source":{"system":"sec-edgar","filing":"0001055726-25-000038","document":"wk-form4_1747861088.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000038/wk-form4_1747861088.xml","form_type":"4"}},{"id":1139366,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45390,"kind":"person","name":"BENITO SIMON X","position":1,"cik":"0001273306","reported_name":"BENITO SIMON X","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:58:04.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":2167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2167},"source":{"system":"sec-edgar","filing":"0001055726-25-000037","document":"wk-form4_1747861076.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000037/wk-form4_1747861076.xml","form_type":"4"}},{"id":1139365,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45390,"kind":"person","name":"BENITO SIMON X","position":1,"cik":"0001273306","reported_name":"BENITO SIMON X","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:58:04.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":2167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":12191,"source":{"system":"sec-edgar","filing":"0001055726-25-000037","document":"wk-form4_1747861076.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000037/wk-form4_1747861076.xml","form_type":"4"}},{"id":1139364,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":34848,"kind":"person","name":"YARNO WENDY L","position":1,"cik":"0001181186","reported_name":"YARNO WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:57:52.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":false,"shares":2167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2167},"source":{"system":"sec-edgar","filing":"0001055726-25-000036","document":"wk-form4_1747861066.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000036/wk-form4_1747861066.xml","form_type":"4"}},{"id":1139363,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":34848,"kind":"person","name":"YARNO WENDY L","position":1,"cik":"0001181186","reported_name":"YARNO WENDY L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-21T20:57:52.000Z","date":"2025-05-21","kind":"exercise","planned":false,"acquired":true,"shares":2167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units vested 100% on May 21, 2025."}],"balance_after":10512,"source":{"system":"sec-edgar","filing":"0001055726-25-000036","document":"wk-form4_1747861066.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000036/wk-form4_1747861066.xml","form_type":"4"}},{"id":1139362,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock Option","published_at":"2025-05-21T20:57:42.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":31950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting schedule for the 31,950 options is as follows: 15,975 shares will vest on May 20, 2027 and 15,975 shares will vest on May 20, 2028."}],"balance_after":31950,"derivative":{"exercise_price":2.13,"expiration_date":"2035-05-20","underlying":"Common Stock","underlying_shares":31950},"source":{"system":"sec-edgar","filing":"0001055726-25-000035","document":"wk-form4_1747861055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000035/wk-form4_1747861055.xml","form_type":"4"}},{"id":1139361,"issuer":{"id":6589,"kind":"organization","name":"INOVIO PHARMACEUTICALS, INC."},"owners":[{"id":45387,"kind":"person","name":"KIES PETER","position":1,"cik":"0001259780","reported_name":"KIES PETER","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Unit","published_at":"2025-05-21T20:57:42.000Z","date":"2025-05-20","kind":"grant","planned":false,"acquired":true,"shares":26100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units is as follows: 8,700 shares will vest on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units is as follows: 8,700 shares will vest on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock.  The vesting schedule for the 26,100 restricted stock units is as follows: 8,700 shares will vest on May 20, 2026; 8,700 shares will vest on May 20, 2027; 8,700 shares will vest on May 20, 2028.  Vested restricted stock units can be settled in shares of common stock, cash or a combination of both."}],"balance_after":26100,"derivative":{"underlying":"Common Stock","underlying_shares":26100},"source":{"system":"sec-edgar","filing":"0001055726-25-000035","document":"wk-form4_1747861055.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1055726/000105572625000035/wk-form4_1747861055.xml","form_type":"4"}}],"next_cursor":"2025-05-21T20:57:42.000000Z,1139361"}